BIOMAT Database Logo BIOMAT Database Logo

Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease. 2003

Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Department of Ophthalmology, University Medical Center Benjamin Franklin, Freie Universität Berlin, Berlin, Germany.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D009901 Optic Nerve Diseases Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect. Cranial Nerve II Diseases,Foster-Kennedy Syndrome,Optic Disc Disorders,Optic Disk Disorders,Optic Neuropathy,Second Cranial Nerve Diseases,Cranial Nerve II Disorder,Neural-Optical Lesion,Disc Disorder, Optic,Disk Disorder, Optic,Disorder, Optic Disc,Foster Kennedy Syndrome,Lesion, Neural-Optical,Neural Optical Lesion,Neural-Optical Lesions,Neuropathy, Optic,Optic Disc Disorder,Optic Disk Disorder,Optic Nerve Disease,Optic Neuropathies,Syndrome, Foster-Kennedy
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005128 Eye Diseases Diseases affecting the eye. Eye Disorders,Eye Disease,Eye Disorder
D005451 Fluorescein Angiography Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature. Fluorescence Angiography,Fundus Fluorescence Photography,Angiography, Fluorescein,Angiography, Fluorescence,Fluorescence Photography, Fundus,Photography, Fundus Fluorescence
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077190 Interferon alpha-2 Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA. IFN-alpha 2,IFN-alpha-2,IFNalpha-2b, Recombinant,Interferon alfa-2a,Interferon alfa-2b,Interferon alpha-2b, Recombinant,Interferon alpha-A,Interferon-alpha 2,Intron A (Interferon),LeIF A,Reaferon,Recombinant Interferon alpha-2a,Recombinant Interferon alpha-2b,Ro 22-8181,Roferon-A,Sch-30500,Viferon,IFNalpha 2b, Recombinant,Interferon alfa 2a,Interferon alfa 2b,Interferon alpha 2,Interferon alpha 2b, Recombinant,Interferon alpha A,Interferon alpha-2a, Recombinant,Recombinant IFNalpha-2b,Recombinant Interferon alpha 2a,Recombinant Interferon alpha 2b,Ro 22 8181,Ro 228181,Roferon A,RoferonA,Sch 30500,Sch30500
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Interferon alfa-2a in the treatment of Behçet's disease.
January 1996, Dermatology (Basel, Switzerland),
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.
May 2008, The Journal of rheumatology,
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
July 2015, Yonsei medical journal,
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Treatment of Adamantiades-Behçet disease with systemic interferon alfa.
August 1998, Archives of dermatology,
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
[Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].
February 2004, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease.
November 2007, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
[Systemic Adamantiades-Behçet's disease: adverse effects of an otherwise successful therapy with interferon-α-2a].
January 2015, Deutsche medizinische Wochenschrift (1946),
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Behçet's disease (Adamantiades-Behçet's disease).
January 2011, Clinical & developmental immunology,
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Ocular involvement in Adamantiades-Behçet's disease in Berlin, Germany.
May 2009, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Lothar Krause, and Julia R Turnbull, and Necip Torun, and Uwe Pleyer, and Christos C Zouboulis, and Michael H Foerster
Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
May 1998, The British journal of ophthalmology,
Copied contents to your clipboard!